高端疫苗 (6547)
高端疫苗 is a TPEx-listed company in Biotech & Medical Care. Revenue for September 2026 was NT$207.19M, up 98.8% from a year earlier. EPS over the last four quarters totals -NT$0.51.
Company profile
Data as of 2026-10-14
- Market
- TPEx-listed
- Industry
- Biotech & Medical Care
- Listed
- 2018-04-17
- Founded
- 2012-10-12
- Paid-in capital
- NT$3.29B
- Common shares issued
- 328,943,644
- Legal name
- 高端疫苗生物製劑股份有限公司
- Website
- http://www.medigenvac.com
Monthly revenue
Data as of 2026-10-15
| Month | Revenue | MoM | YoY |
|---|---|---|---|
| 2026-09 | NT$207.19M | -12.4% | +98.8% |
| 2026-08 | NT$236.39M | +399.0% | +416.9% |
Year to date: +52.7% vs. last year (Jan–Sep 2026)
Earnings per share (EPS)
Data as of 2026-06-30
| Quarter | EPS (NT$) |
|---|---|
| 2026 Q2 | 0.07 |
| 2026 Q1 | -0.09 |
| 2025 Q4 | -0.42 |
| 2025 Q3 | -0.07 |
| 2025 Q2 | -0.31 |
| 2025 Q1 | -0.06 |
| 2024 Q4 | -0.06 |
| 2024 Q3 | 0.00 |
Last four quarters: -NT$0.51
Dividends
Data as of 2026-10-14
| Period | Cash (NT$) | Stock (NT$) | Ex-dividend | Ex-rights | Paid |
|---|---|---|---|---|---|
| 2025 年度 | 0.00 | 0.00 | — | — | — |
Shareholder structure
Data as of 2026-10-16
| Holding range | Holders | Share of total |
|---|---|---|
| 1–999 shares | 26,285 | 0.7% |
| 1,000–5,000 shares | 17,638 | 10.7% |
| 5,001–10,000 shares | 2,892 | 6.3% |
| 10,001–15,000 shares | 1,058 | 3.9% |
| 15,001–20,000 shares | 620 | 3.2% |
| 20,001–30,000 shares | 702 | 5.1% |
| 30,001–40,000 shares | 373 | 3.8% |
| 40,001–50,000 shares | 264 | 3.4% |
| 50,001–100,000 shares | 497 | 10.0% |
| 100,001–200,000 shares | 248 | 9.8% |
| 200,001–400,000 shares | 101 | 7.7% |
| 400,001–600,000 shares | 29 | 4.1% |
| 600,001–800,000 shares | 12 | 2.4% |
| 800,001–1,000,000 shares | 5 | 1.3% |
| 1,000,001+ shares | 26 | 27.7% |
TDCC data for 2026-10-16: 26 holders own more than 1,000 lots (27.7% of shares), and 26,285 hold less than one lot (0.7%).
Institutional net buying (last 20 trading days)
Data as of 2026-10-19
| Date | Foreign | Trust | Dealers | Total |
|---|---|---|---|---|
| 2026-10-19 | -626 | 0 | -192 | -818 |
| 2026-10-16 | 407 | 0 | -19 | 388 |
| 2026-10-15 | 536 | 0 | -100 | 436 |
| 2026-10-14 | -81 | 0 | -2 | -83 |
| 2026-10-13 | -960 | 0 | 17 | -943 |
| 2026-10-12 | -2,046 | 0 | 23 | -2,023 |
| 2026-10-08 | -123 | 0 | 19 | -104 |
| 2026-10-07 | 521 | 0 | 5 | 526 |
| 2026-10-06 | 264 | 0 | -15 | 249 |
| 2026-10-05 | 330 | 0 | -12 | 318 |
| 2026-10-02 | -1,291 | 0 | -82 | -1,373 |
| 2026-10-01 | -583 | 0 | 137 | -446 |
| 2026-09-30 | 1,692 | 0 | -82 | 1,610 |
| 2026-09-29 | 740 | 0 | -95 | 645 |
| 2026-09-24 | -752 | 0 | 16 | -736 |
| 2026-09-23 | 1,372 | 0 | -24 | 1,348 |
| 2026-09-22 | 210 | 0 | 56 | 266 |
| 2026-09-21 | 44 | 0 | -61 | -17 |
| 2026-09-18 | -1,077 | 0 | 83 | -994 |
| 2026-09-17 | 57 | 0 | -3 | 54 |
Unit: lots (1,000 shares). Over the last 20 trading days, institutions were net sellers of 1,697 lots.
Price (official close)
Data as of 2026-10-19
Last close NT$50.80 (2026-10-19); 52-week range NT$33.50–72.20.
Sources
- Source: Taiwan Stock Exchange and Taipei Exchange public data
- Source: Taiwan Stock Exchange and Taipei Exchange public data
- Source: Market Observation Post System (MOPS)
- Source: Taiwan Stock Exchange and Taipei Exchange public data
- Source: Taiwan Depository & Clearing Corporation public data
- Source: Taiwan Stock Exchange and Taipei Exchange public data
- Source: Taiwan Stock Exchange and Taipei Exchange public data
Charts, drawing tools, and the P/E calculator are in the app, free to use.